Max Robotics — Global Service Robot Directory + US Certification

About

Dr. Mehdi Boubaddi is a leading surgical researcher whose work centers on advancing minimally invasive pancreatic surgery, with a particular focus on improving patient outcomes and surgical safety. His most impactful contribution to date is the development of the Conversion Risk Score (CRS), a predictive tool designed to identify patients at high risk for conversion during minimally invasive left pancreatectomy (MILP). This work, published in 2025 and already garnering 4 citations, addresses a critical clinical challenge: conversion occurs in 15-30% of MILP cases and is strongly associated with severe postoperative complications. By systematically analyzing risk factors for conversion, Dr. Boubaddi has provided surgeons with a practical, evidence-based framework to better stratify patients preoperatively, potentially reducing morbidity and enhancing surgical planning. His research bridges the gap between complex operative data and actionable clinical decision-making, offering tangible benefits for both surgeons and patients. As an emerging authority in hepatopancreatobiliary surgery, Dr. Boubaddi’s work represents a significant step toward safer, more predictable minimally invasive procedures, and his CRS is poised to become a standard reference in the field.